FDA Import Refusal AEK-1876875-2/21/1 — Abbot India Ltd
The FDA refused shipment AEK-1876875-2/21/1 from Abbot India Ltd (India) on Nov 17, 2022. The refused product falls under Drugs and Biologics — PANCRELIPASE (ENZYME). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 17, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64ECE03 PANCRELIPASE (ENZYME)
- Charges
- 75